AWZ-1066-S
- Generic Name
- AWZ-1066-S
Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide Drug
Phase 1
Terminated
- Conditions
- OnchocerciasisFilariasis, Lymphatic
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-10-20
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Liverpool School of Tropical Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT05084560
- Locations
- 🇬🇧
Liverpool University Hospitals NHS Foundation Trust, Liverpool, Merseyside, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath